QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-hold-on-inspire-medical-systems-lowers-price-target-to-90

Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price ta...

 inspire-medical-publishes-inspire-v-clinical-outcomes-data-from-singapore-clinical-study-and-limited-market-release-in-us-including-single-site-experience-at-two-leading-centers-data-to-be-presented-at-aao-hns-and-isss-meetings

Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...

 evercore-isi-group-maintains-outperform-on-inspire-medical-systems-lowers-price-target-to-125

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the p...

 kenneth-griffin-reports-58-passive-stake-in-inspire-medical-systems-as-of-sept-29

https://www.sec.gov/Archives/edgar/data/1609550/000110465925097180/xslSCHEDULE_13G_X01/primary_doc.xml

 ubs-downgrades-inspire-medical-systems-to-neutral-lowers-price-target-to-89

UBS analyst Danielle Antalffy downgrades Inspire Medical Systems (NYSE:INSP) from Buy to Neutral and lowers the price target...

Core News & Articles

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Mont-Saint-Guibert, Belgium – September 15, 2025,...

 evercore-isi-group-initiates-coverage-on-inspire-medical-systems-with-outperform-rating-announces-price-target-of-150

Evercore ISI Group analyst Daniel Markowitz initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Outperform rati...

 inspire-medical-systems-affirms-fy2025-gaap-eps-guidance-of-040-050-vs-227-est-affirms-fy2025-sales-guidance-of-900000m-910000m-vs-949364m-est

Inspire Medical Systems (NYSE:INSP) affirms FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.40-$0.50 vs $2.27 analyst estimate....

 inspire-medical-cfo-rick-buchholz-to-step-down-by-year-end-will-stay-in-advisory-role-through-february-2026

Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...

 leerink-partners-maintains-market-perform-on-inspire-medical-systems-lowers-price-target-to-97

Leerink Partners analyst Mike Kratky maintains Inspire Medical Systems (NYSE:INSP) with a Market Perform and lowers the pric...

 inspire-medical-stock-strays-off-course-amid-structural-setback

Inspire Medical's chart structure signals weakness after a major breakdown. Here's why investors may want to avoid the ...

 stock-market-today-us-futures-edge-higher-as-investors-await-earnings-from-mcdonalds-uber-and-walt-disney

US stock futures rose on Wed. after falling on Thurs. Trump threatened tariffs on imported pharma up to 250%. Bond yields down ...

 inspire-medical-plunges-on-outlook-cut-weak-v-system-rollout-analysts-react

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved I...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION